Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Meningococcal Vaccines Market to reach USD 5.88 billion by 2032.

Global Meningococcal Vaccines Market Size study, by Vaccine Serotype (MenACWY, MenB & Manic, MenC, MenA, MenAC), by Vaccine Type (Conjugate, Polysaccharide, Subcapsular), by End User (Pediatric, Adult, Travelers) and Regional Forecasts 2022-2032

Product Code: HLSDT-79084373
Publish Date: 10-08-2024
Page: 200

Global Meningococcal Vaccines Market is valued approximately at USD 3.48 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.0% over the forecast period 2024-2032. Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, encompasses severe infections like meningitis and bacteremia, which, if untreated, can result in a fatality rate as high as 50%. This disease primarily affects the brain and spinal cord linings and has the potential to cause large-scale epidemics. Transmission occurs through direct contact with respiratory or throat secretions from infected individuals or asymptomatic carriers. Out of the 12 serogroups of N. meningitidis, serogroups A, B, C, W, and Y are the major culprits responsible for the majority of global cases. The unpredictable circulation of these serogroups across different age groups and regions necessitates the availability of vaccines targeting each serogroup.
The market for meningococcal vaccines is poised for significant growth, driven by increasing adoption in national immunization programs across various countries and a rise in meningococcal outbreaks globally. These outbreaks have escalated the demand for effective vaccines, thereby propelling market growth. However, stringent regulatory frameworks for new vaccine approvals and product recalls due to contamination issues pose challenges to market expansion. On a positive note, ongoing research and development in meningococcal vaccines and rising global healthcare expenditure present lucrative growth opportunities for the market.
North America led the market in 2023, holding a revenue share of 53%, followed by Europe. The dominance of North America is attributed to favorable governmental recommendations, substantial R&D investments, a robust healthcare infrastructure, and extensive awareness campaigns. In contrast, the Asia Pacific region is anticipated to witness rapid growth during the forecast period. Factors such as a growing pediatric population and proactive government initiatives to combat the increasing prevalence of the disease contribute to this growth. Non-profit organizations in the region also play a crucial role in spreading awareness among the public and healthcare professionals, further boosting vaccine adoption.
Major market players included in this report are:
GlaxoSmithKline plc
Pfizer Inc.
Sanofi Pasteur
Merck & Co., Inc.
Novartis AG
CSL Limited
Johnson & Johnson
Bharat Biotech International Limited
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd.
Biological E Limited
Chongqing Zhifei Biological Products Co., Ltd.
Beijing Tiantan Biological Products Co., Ltd.
Hualan Biological Engineering Inc.
Walvax Biotechnology Co., Ltd.

The detailed segments and sub-segment of the market are explained below:
By Vaccine Serotype:
• MenACWY
• MenB & Manic
• MenC
• MenA
• MenAC
By Vaccine Type:
• Conjugate
• Polysaccharide
• Subcapsular
By End User:
• Pediatric
• Adult
• Travelers
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Chapter 1. Global Meningococcal Vaccines Market Executive Summary
1.1. Global Meningococcal Vaccines Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Vaccine Serotype
1.3.2. By Vaccine Type
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Meningococcal Vaccines Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Meningococcal Vaccines Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption in Immunization Programs
3.1.2. Surge in Meningococcal Outbreaks
3.2. Market Challenges
3.2.1. Stringent Government Regulations
3.2.2. Product Recalls Due to Contamination
3.3. Market Opportunities
3.3.1. Increase in R&D Activities
3.3.2. Rising Healthcare Expenditure

Chapter 4. Global Meningococcal Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Meningococcal Vaccines Market Size & Forecasts by Vaccine Serotype 2022-2032
5.1. Segment Dashboard
5.2. Global Meningococcal Vaccines Market: Vaccine Serotype Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. MenACWY
5.2.2. MenB & Manic
5.2.3. MenC
5.2.4. MenA
5.2.5. MenAC

Chapter 6. Global Meningococcal Vaccines Market Size & Forecasts by Vaccine Type 2022-2032
6.1. Segment Dashboard
6.2. Global Meningococcal Vaccines Market: Vaccine Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Conjugate
6.2.2. Polysaccharide
6.2.3. Subcapsular

Chapter 7. Global Meningococcal Vaccines Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Meningococcal Vaccines Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Pediatric
7.2.2. Adult
7.2.3. Travelers

Chapter 8. Global Meningococcal Vaccines Market Size & Forecasts by Region 2022-2032
8.1. North America Meningococcal Vaccines Market
8.1.1. U.S. Meningococcal Vaccines Market
8.1.1.1. Vaccine Serotype breakdown size & forecasts, 2022-2032
8.1.1.2. Vaccine Type breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Meningococcal Vaccines Market
8.2. Europe Meningococcal Vaccines Market
8.2.1. U.K. Meningococcal Vaccines Market
8.2.2. Germany Meningococcal Vaccines Market
8.2.3. France Meningococcal Vaccines Market
8.2.4. Spain Meningococcal Vaccines Market
8.2.5. Italy Meningococcal Vaccines Market
8.2.6. Rest of Europe Meningococcal Vaccines Market
8.3. Asia-Pacific Meningococcal Vaccines Market
8.3.1. China Meningococcal Vaccines Market
8.3.2. India Meningococcal Vaccines Market
8.3.3. Japan Meningococcal Vaccines Market
8.3.4. Australia Meningococcal Vaccines Market
8.3.5. South Korea Meningococcal Vaccines Market
8.3.6. Rest of Asia Pacific Meningococcal Vaccines Market
8.4. Latin America Meningococcal Vaccines Market
8.4.1. Brazil Meningococcal Vaccines Market
8.4.2. Mexico Meningococcal Vaccines Market
8.4.3. Rest of Latin America Meningococcal Vaccines Market
8.5. Middle East & Africa Meningococcal Vaccines Market
8.5.1. Saudi Arabia Meningococcal Vaccines Market
8.5.2. South Africa Meningococcal Vaccines Market
8.5.3. Rest of Middle East & Africa Meningococcal Vaccines Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GlaxoSmithKline plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Pfizer Inc.
9.3.3. Sanofi Pasteur
9.3.4. Merck & Co., Inc.
9.3.5. Novartis AG
9.3.6. CSL Limited
9.3.7. Johnson & Johnson
9.3.8. Bharat Biotech International Limited
9.3.9. Serum Institute of India Pvt. Ltd.
9.3.10. Sinovac Biotech Ltd.
9.3.11. Biological E Limited
9.3.12. Chongqing Zhifei Biological Products Co., Ltd.
9.3.13. Beijing Tiantan Biological Products Co., Ltd.
9.3.14. Hualan Biological Engineering Inc.
9.3.15. Walvax Biotechnology Co., Ltd.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now